EL
COMPANY

Elsevier

Elsevier is a scientific publishing and research intelligence platform for institutions and professionals.

Analyst Perspective

Elsevier is a Netherlands-headquartered scientific publishing and research information business within RELX Group plc. It sells access to proprietary journals, databases, analytics tools, clinical decision support products, education platforms and research workflow software. Its portfolio includes ScienceDirect for full-text scientific content, Scopus and SciVal for research analytics, Mendeley for reference management, and specialist products for clinical, chemistry and biomedical use cases. The business primarily monetises through institutional subscriptions, platform licensing and other recurring contracts with universities, libraries, hospitals, governments, pharmaceutical companies and corporate R&D teams. It also earns from open access publishing fees, pay-per-view content, education software, and smaller media-related revenue streams such as advertising, reprints and sponsored supplements across owned journal properties.

Analyst Signal Briefing

Updated: 23 Jul 2026

Elsevier has intensified efforts to protect its intellectual property by joining a class-action lawsuit against Google regarding unauthorised AI training data usage, a move occurring alongside a landmark $1.5 billion settlement between publishers and Anthropic. Operationally, the company expanded LeapSpace™ with agentic capabilities to automate research workflows and progressed its partnership with NHS 24 to enhance clinical decision-making. These developments reinforce Elsevier’s dual strategy of defending its content licensing markets while scaling integrated, AI-driven digital solutions across the research and healthcare sectors.

Explorer Tier

Start exploring for free

Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.

Free
  • View public Company Profiles
  • Save/watch companies
  • Build your first Watchlist
  • Access additional market signals

Category Differentiation

Elsevier is a scientific publishing and research information company, not a general consumer media publisher or a standalone foundational AI model provider. It competes more directly with academic information groups such as Clarivate, Springer Nature and Wiley than with mainstream news publishers.

Elsevier: About

Elsevier combines proprietary content ownership with software and analytics distribution. It creates and licenses high-value scientific and medical content, then layers discovery, benchmarking, workflow and decision-support tools on top of that corpus. Revenue is driven mainly by recurring institutional agreements, with additional monetisation from author-side publishing charges, transactional access, education products and specialised media inventory tied to its journals.

How Elsevier Works & Monetises

Business model analysis and core revenue streams

Elsevier uses a hybrid recurring-revenue model led by subscription and licensing fees for content databases, analytics platforms and workflow software. It also charges article processing charges for open-access publishing, pay-per-view and content purchases for individual access, institutional SaaS subscriptions for education and clinical tools, and media-related fees for advertising, reprints and sponsored supplements.

Revenue Channels

Institutional content subscriptions and licencesContent Subscription
Research analytics and workflow software subscriptionsSoftware Subscription
Open access publishing feesService Fee
Pay-per-view articles, eBooks and individual product purchasesOne-time Sale
Advertising, reprints and supplementsService Fee

Side-by-Side Comparisons

Compare Elsevier directly with top competitors

Elsevier: Key Competitors & Alternatives

View full competitor landscape

Recent Signals (Elsevier)

techcrunchJul 21, 2026

Anthropic's $1.5B Copyright Settlement Approved

Anthropic reached a court-approved $1.5 billion class-action settlement resolving authors’ claims that its Claude models were trained using pirated books. The fund will compensate affected authors and publishers — roughly 500,000 works are estimated eligible, with proposed payments of about $3,000 per eligible work — and cancels a planned jury trial. Judge Araceli Martinez-Olguin gave final approval after earlier proceedings in which Judge William Alsup found Anthropic had used pirated sources (including piracy sites) but also held that training on copyrighted books can, in some circumstances, be fair use. Because Anthropic settled rather than appeal, the case will not create binding nationwide precedent; related lawsuits against Google, Meta, Midjourney and OpenAI remain active. Participating plaintiff firms are slated to receive over $100 million in fees.

Read original source
ElsevierJul 14, 2026

How NHS 24 and Elsevier are turning uncertainty into confident, clinically safe decisions

The featured story on the Elsevier About page has been updated from 'The future we build could depend on research we don’t read' to a new case study about NHS 24, highlighting a partnership to improve clinical decision-making.

Read original source
AdweekJul 14, 2026

Book Publishers Sue Google Over AI Training

A coalition of major publishers and authors — including Hachette Book Group, Cengage, Elsevier, novelist Scott Turow and S.C.R.I.B.E. — filed a class-action lawsuit against Google on July 14, 2026 in the U.S. District Court for the Southern District of New York. The complaint alleges Google trained its Gemini models on copyrighted books sourced from Google Books and titles uploaded to Google Play without permission, and removed or altered copyright information to conceal that use. Plaintiffs cite internal Google estimates of potential liabilities in the tens to hundreds of billions and say the practice displaces sales and undermines licensing markets. The filing is part of a broader wave of litigation over AI training data and follows publisher tactics such as crawler blocks and threats to delist from search.

Read original source

Elsevier: Frequently Asked Questions

What is Elsevier?

Elsevier is a scientific publishing, research information and workflow software business within RELX, serving academic, clinical and R&D markets.

Who uses Elsevier?

Universities, libraries, researchers, hospitals, government agencies, pharmaceutical companies, educators and corporate R&D teams use its platforms and content.

How does Elsevier make money?

It mainly earns from institutional subscriptions and licences, plus open-access publishing fees, transactional content sales, software subscriptions and smaller media-related revenues.

Company Facts

Founded
1880
Headquarters
Netherlands
Core Segment
Publisher & Media Owner
Company Size
>5,000
Official Link
elsevier.com